Humanity and Health Clinical Trial Center
Hong Kong 999077
0 studies enrolling now ยท 1 studies all time
What they study most
Carcinoma, Hepatocellular
Studies at this site
Regorafenib-pembrolizumab vs. TACE/TARE in Intermediate Stage HCC Beyond Up-to-7
โ Stopped early